Catalysts, reliability, and smart-money flow — every figure traced to a primary source. No predictions. No advice.
Free preview · Pro · $9/mo
Built for the retail investor who refuses to be downstream.
Twelve months of forward visibility across 30+ names. When a date slips, the diff is surfaced — never silently updated.
Per-ticker accuracy scoring against historical guidance, with sector base rates for context. The disclosure track record, quantified.
Insider trades, congressional positions, KOL payments, ETF flow, lobbying spend — surfaced inside every company view.
SEC filings, ClinicalTrials.gov edits, FDA notices, IR releases — verbatim quotes you can audit. Plain English by default.
Where every figure comes from, how we handle uncertainty, and what we refuse to do.
Catalysts are announced at varying precision. A PDUFA gets a hard date; corporate guidance might only narrow to a quarter; analyst expectation might be just “later this year.” We surface the actual precision the source provided — never invent specificity that isn’t there.
A press release might say Q2 while an 8-K says June 18. When that happens, we don’t pick silently. The disclosure timeline shows both quotes side-by-side with their dates and source pills — you decide what to trust.
Most catalyst trackers are a layer of opinion sitting on top of public data. We’re a transparent surface. Here’s the discipline:
Found a date that doesn’t match the source? A quote we got wrong? An obvious public dataset we should be ingesting? Tell us. Corrections post publicly.